[DPHARMA] QoQ TTM Result on 30-Sep-2024 [#3]

Stock
[DPHARMA] DUOPHARMA BIOTECH BERHAD
Announcement Date
08-Nov-2024
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2024
Quarter
30-Sep-2024 [#3]
Profit Trend
QoQ- 13.4%
YoY- -8.55%
Quarter Report
Latest QR
Upcoming QR
DPHARMA's Result
DPHARMA's Financial Summary
View:
Show?
TTM Result
30/09/24 30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 CAGR
Revenue 787,525 748,028 697,220 704,727 689,186 697,025 711,251 7.00%
PBT 69,615 60,522 55,077 63,268 71,581 81,539 86,497 -13.44%
Tax -13,552 -11,084 -9,787 -10,622 -10,276 -12,855 -14,043 -2.33%
NP 56,063 49,438 45,290 52,646 61,305 68,684 72,454 -15.67%
-
NP to SH 56,063 49,438 45,290 52,646 61,305 68,684 72,454 -15.67%
-
Tax Rate 19.47% 18.31% 17.77% 16.79% 14.36% 15.77% 16.24% -
Total Cost 731,462 698,590 651,930 652,081 627,881 628,341 638,797 9.42%
-
Net Worth 692,598 692,598 682,979 682,979 673,359 670,448 666,567 2.57%
Dividend
30/09/24 30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 CAGR
Div 26,934 26,934 22,103 22,103 21,929 21,929 21,874 14.83%
Div Payout % 48.04% 54.48% 48.81% 41.99% 35.77% 31.93% 30.19% -
Equity
30/09/24 30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 CAGR
Net Worth 692,598 692,598 682,979 682,979 673,359 670,448 666,567 2.57%
NOSH 961,942 961,942 961,942 961,942 961,942 961,942 952,239 0.67%
Ratio Analysis
30/09/24 30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 CAGR
NP Margin 7.12% 6.61% 6.50% 7.47% 8.90% 9.85% 10.19% -
ROE 8.09% 7.14% 6.63% 7.71% 9.10% 10.24% 10.87% -
Per Share
30/09/24 30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 CAGR
RPS 81.87 77.76 72.48 73.26 71.65 72.77 74.69 6.29%
EPS 5.83 5.14 4.71 5.47 6.37 7.17 7.61 -16.23%
DPS 2.80 2.80 2.30 2.30 2.30 2.30 2.30 13.97%
NAPS 0.72 0.72 0.71 0.71 0.70 0.70 0.70 1.89%
Adjusted Per Share Value based on latest NOSH - 961,942
30/09/24 30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 CAGR
RPS 81.87 77.76 72.48 73.26 71.65 72.46 73.94 7.00%
EPS 5.83 5.14 4.71 5.47 6.37 7.14 7.53 -15.64%
DPS 2.80 2.80 2.30 2.30 2.30 2.28 2.27 14.97%
NAPS 0.72 0.72 0.71 0.71 0.70 0.697 0.6929 2.58%
Price Multiplier on Financial Quarter End Date
30/09/24 30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 CAGR
Date 30/09/24 28/06/24 29/03/24 29/12/23 29/09/23 30/06/23 31/03/23 -
Price 1.36 1.26 1.20 1.26 1.20 1.30 1.56 -
P/RPS 1.66 1.62 1.66 1.72 1.67 1.79 2.09 -14.19%
P/EPS 23.34 24.52 25.49 23.02 18.83 18.13 20.50 9.00%
EY 4.29 4.08 3.92 4.34 5.31 5.52 4.88 -8.21%
DY 2.06 2.22 1.92 1.83 1.92 1.77 1.47 25.15%
P/NAPS 1.89 1.75 1.69 1.77 1.71 1.86 2.23 -10.41%
Price Multiplier on Announcement Date
30/09/24 30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 CAGR
Date 08/11/24 15/08/24 23/05/24 22/02/24 08/11/23 24/08/23 22/05/23 -
Price 1.25 1.17 1.26 1.21 1.22 1.19 1.44 -
P/RPS 1.53 1.50 1.74 1.65 1.70 1.64 1.93 -14.30%
P/EPS 21.45 22.77 26.76 22.11 19.14 16.59 18.93 8.66%
EY 4.66 4.39 3.74 4.52 5.22 6.03 5.28 -7.96%
DY 2.24 2.39 1.83 1.90 1.89 1.93 1.60 25.06%
P/NAPS 1.74 1.62 1.77 1.70 1.74 1.70 2.06 -10.61%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment